3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Heart Failure
1
Interventions
Standard of Care
2
Rituximab
2
Carvedilol
2
sacubitril and valsartan sodium hydrate drug combination
1
pegfilgrastim
1
obinutuzumab
1
empagliflozin
1
dapagliflozin
1
acalabrutinib
1
Vincristine
1
Vascular Stiffness
1
Valsartan
1
Specimen Handling
1
Pulse Wave Analysis
1
Prednisolone
1
Practice Guidelines as Topic
1
Palliative Care
1
Nutrition Assessment
1
Mesenchymal Stem Cell Transplantation
1
Lenalidomide
1
Health Information Exchange
1
Exercise
1
Eplerenone
1
Electronic Health Records
1
Electrocardiography
1
Echocardiography
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Failure
×
Valsartan
×
1 year
×
Clear all
NCT05194111
2026-03-13
TREAT-HF
Virginia Commonwealth University
Phase 1/2
Recruiting
53 enrolled